
Posted on 10月 8, 202410/8/24
OpenAI’s new o1 Series models’ focus on “reasoning” and what it could mean to lifesciences brands and marketers

Posted on 5月 13, 20245/13/24
Leveraging Generative AI in Brand Planning: Insights from Second Annual Pharmaceutical Brand Planning Survey

Posted on 5月 12, 20245/12/24
Maximizing Sales Impact in a Hybrid World

Posted on 3月 1, 20243/1/24
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization

Posted on 6月 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics

Posted on 4月 27, 20234/27/23
The Necessity of Mapping the Tumor Journey for Oncology Marketers

Posted on 4月 4, 20234/4/23
Achieving Digital Enlightenment in 2023 and Beyond

Posted on 3月 30, 20233/30/23
Next Generation Brand Planning: Fueling Brand Plan Efficiency Through Seamless Integration

Posted on 1月 20, 20231/20/23
Missed Connection or Meant to Be?

Posted on 8月 18, 20228/18/22